Table 2

 Evolution of the patients’ functional status by New York Heart Association functional class

Time pointTrimetazidine groupControl group
IIIIIIIVTotalIIIIIIIVTotal
Baseline0111723001018331
6 months1111623001017431
12 months42040280223429
18 month42110260124328